Sunrest Lifescience Limited (NSE:SUNREST)

India flag India · Delayed Price · Currency is INR
36.30
+0.20 (0.55%)
Apr 29, 2026, 3:03 PM IST
-32.15%
Market Cap 155.77M
Revenue (ttm) 520.34M
Net Income (ttm) 17.60M
Shares Out 4.29M
EPS (ttm) 4.10
PE Ratio 8.86
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,200
Average Volume 7,040
Open 37.40
Previous Close 36.10
Day's Range 36.30 - 37.40
52-Week Range 29.55 - 61.00
Beta 0.33
RSI 42.34
Earnings Date May 26, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2017
Employees 210
Stock Exchange National Stock Exchange of India
Ticker Symbol SUNREST
Full Company Profile

Financial Performance

In fiscal year 2025, Sunrest Lifescience's revenue was 334.13 million, an increase of 13.33% compared to the previous year's 294.83 million. Earnings were 20.05 million, an increase of 788.48%.

Financial Statements

News

There is no news available yet.